Cumberland Pharmaceuticals Inc (CPIX)

Jan 05, 2025

Cumberland Pharmaceuticals (NASDAQ:CPIX) Coverage Initiated at StockNews.com - Defense World

Jan 05, 2025

Dec 30, 2024

Cumberland Pharmaceuticals director James Jones acquires $1,317 in stock By Investing.com - Investing.com Nigeria

Dec 30, 2024

Dec 30, 2024

Cumberland Pharmaceuticals CEO AJ Kazimi purchases $1317 in stock By Investing.com - Investing.com Nigeria

Dec 30, 2024

Dec 30, 2024

Cumberland Pharmaceuticals director Krogulski buys $8,209 in stock By Investing.com - Investing.com Canada

Dec 30, 2024

Dec 30, 2024

Cumberland Pharmaceuticals director Caroline Young acquires $256 in stock By Investing.com - Investing.com Canada

Dec 30, 2024

Dec 30, 2024

Cumberland Pharmaceuticals director Krogulski buys $8,209 in stock - Investing.com

Dec 30, 2024

Dec 30, 2024

Cumberland Pharmaceuticals director James Jones acquires $1,317 in stock - Investing.com India

Dec 30, 2024

Dec 30, 2024

Cumberland Pharmaceuticals CEO AJ Kazimi purchases $1317 in stock - Investing.com

Dec 30, 2024

Dec 28, 2024

Cumberland Pharmaceuticals (NASDAQ:CPIX) Now Covered by StockNews.com - Defense World

Dec 28, 2024

Dec 27, 2024

Athira Pharma (NASDAQ:ATHA) Stock Quotes, Forecast and News Summary - Benzinga

Dec 27, 2024

Dec 20, 2024

StockNews.com Begins Coverage on Cumberland Pharmaceuticals (NASDAQ:CPIX) - Defense World

Dec 20, 2024

Dec 20, 2024

Cumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Crosses Above 200-Day Moving Average – Here’s Why - Defense World

Dec 20, 2024

Dec 12, 2024

StockNews.com Initiates Coverage on Cumberland Pharmaceuticals (NASDAQ:CPIX) - Defense World

Dec 12, 2024

Dec 10, 2024

FDA APPROVES ACETADOTE® sNDA - Citizentribune

Dec 10, 2024

Dec 10, 2024

3 Promising Penny Stocks With Market Caps Under $2B In US - Simply Wall St

Dec 10, 2024

Dec 10, 2024

Cumberland Pharmaceuticals stock pops - Nashville Post

Dec 10, 2024

Dec 10, 2024

Cumberland Stock Soars 90% After FDA Approval for Acetadote Dosing Change - GuruFocus.com

Dec 10, 2024

Dec 10, 2024

Stock Skyrockets! Discover What’s Fueling This Company’s Massive Surge. - elblog.pl

Dec 10, 2024

Dec 10, 2024

Gold Gains Over 1%; Ollie's Bargain Outlet Shares Jump After Q3 Earnings - Benzinga

Dec 10, 2024

Dec 10, 2024

Why Is Cumberland Pharmaceuticals Stock Trading Over 100% on Tuesday? - Benzinga

Dec 10, 2024

Dec 10, 2024

Cumberland Pharma Stock Hits 16-Month High After FDA Approves Liver Drug Regimen: Retail’s Thrilled - MSN

Dec 10, 2024

Dec 10, 2024

Cumberland (CPIX) Celebrates FDA Nod With Market Rally - Stocks Telegraph

Dec 10, 2024

Dec 10, 2024

FDA Approves Simplified Dosing For Cumberland's Acetadote - Contract Pharma

Dec 10, 2024

Dec 10, 2024

CPIX stock touches 52-week high at $2.92 amid market fluctuations - Investing.com

Dec 10, 2024

Dec 09, 2024

Cumberland Pharma Shares Rise 56% After FDA Approves Liver Drug Acetadote - MarketWatch

Dec 09, 2024

Dec 09, 2024

Cumberland Pharma Secures FDA Approval for Breakthrough Acetadote Dosing Innovation - StockTitan

Dec 09, 2024

Dec 06, 2024

Cumberland Pharmaceuticals director James Jones buys $1,754 in stock By Investing.com - Investing.com South Africa

Dec 06, 2024

Dec 05, 2024

Cumberland Pharmaceuticals CEO A.J. Kazimi buys $1,754 in stock - Investing.com India

Dec 05, 2024

Dec 05, 2024

Cumberland Pharmaceuticals director Caroline Young buys $755 in stock By Investing.com - Investing.com Nigeria

Dec 05, 2024

Dec 05, 2024

Cumberland Pharmaceuticals director Caroline Young buys $755 in stock - Investing.com

Dec 05, 2024

Dec 05, 2024

Cumberland Pharmaceuticals director James Jones buys $1,754 in stock - Investing.com

Dec 05, 2024

Dec 05, 2024

Cumberland Pharmaceuticals director Kenneth Krogulski buys $9,347 in stock - Investing.com

Dec 05, 2024

Nov 29, 2024

Cumberland Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 - Marketscreener.com

Nov 29, 2024

Nov 27, 2024

Cumberland Pharmaceuticals (NASDAQ:CPIX) Now Covered by Analysts at StockNews.com - Defense World

Nov 27, 2024

Nov 26, 2024

Cumberland Pharma stock hits 52-week low at $1.04 By Investing.com - Investing.com South Africa

Nov 26, 2024

Nov 25, 2024

Cumberland Pharma stock hits 52-week low at $1.04 - Investing.com

Nov 25, 2024

Nov 25, 2024

Newly Released Insights in to the Artificial Saliva Market Insights - WhaTech

Nov 25, 2024

Nov 20, 2024

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q3 2024 Earnings Call Transcript - MSN

Nov 20, 2024

Nov 20, 2024

Corneal Ulcer Treatment Market 2034: Clinical Trials, Medication, Prevalence, Incidence, Therapies, EMA, PDMA, FDA Approvals, and Companies by DelveInsight - The Globe and Mail

Nov 20, 2024

Nov 19, 2024

Ibuprofen Injection Shows Better Real-World Outcomes in Comparative Study - Pharmacy Practice News

Nov 19, 2024

Nov 15, 2024

Cumberland Pharma stock hits 52-week low at $1.07 - Investing.com

Nov 15, 2024

Nov 15, 2024

Cumberland Pharma stock hits 52-week low at $1.07 By Investing.com - Investing.com UK

Nov 15, 2024

Nov 12, 2024

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Purchased by Cumberland Partners Ltd - MarketBeat

Nov 12, 2024

Nov 10, 2024

Ibuprofen injection exhibits kidney safety with cost benefits over ketorolac: Study - Medical Dialogues

Nov 10, 2024

Nov 10, 2024

Cumberland Pharmaceuticals Third Quarter 2024 Earnings: US$0.11 loss per share (vs US$0.073 loss in 3Q 2023) - Yahoo Canada Finance

Nov 10, 2024

Nov 09, 2024

Cumberland Pharmaceuticals Inc. (CPIX) Quarterly 10-Q Report - Quartzy

Nov 09, 2024

Nov 08, 2024

Cumberland Pharmaceuticals Inc (CPIX) Q3 2024 Earnings Call Highlights: Navigating Challenges ... By GuruFocus - Investing.com Canada

Nov 08, 2024

Nov 08, 2024

FDA Grants Orphan Drug Designation to Ifetroban for Treatment of Duchenne Muscular Dystrophy-Associated Cardiomyopathy - Pharmacy Times

Nov 08, 2024

Nov 08, 2024

Cumberland: Q3 Earnings Snapshot - mySA

Nov 08, 2024

Nov 08, 2024

Cumberland Pharmaceuticals Reports Q3 2024 Earnings and Developments - TipRanks

Nov 08, 2024